{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:50:07Z","timestamp":1762458607921,"version":"build-2065373602"},"reference-count":16,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T00:00:00Z","timestamp":1653609600000},"content-version":"vor","delay-in-days":4986,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","fertstert.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Fertility and Sterility"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.fertnstert.2007.07.1326","type":"journal-article","created":{"date-parts":[[2008,4,19]],"date-time":"2008-04-19T09:07:36Z","timestamp":1208596056000},"page":"1144-1148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Clinical, endocrine, and metabolic effects of acarbose, a \u03b1-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome"],"prefix":"10.1016","volume":"90","author":[{"given":"Semih","family":"Tu\u011frul","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tayfun","family":"Kutlu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oya","family":"Pekin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elif","family":"Ba\u011flam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin","family":"K\u0131yak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d6zay","family":"Oral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.fertnstert.2007.07.1326_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199509283331307","article-title":"Polycystic ovary syndrome","volume":"333","author":"Franks","year":"1995","journal-title":"N Eng J Med"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib2","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-2007-1016294","article-title":"Role of the hyperinsulinemia in the pathogenesis of the polycystic ovary syndrome and its clinical implications","volume":"15","author":"Nestler","year":"1997","journal-title":"Semin Reprod Endocrinol"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib3","first-page":"3299","article-title":"The insulin sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome","volume":"81","author":"Dunaif","year":"1996","journal-title":"J Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib4","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/S0889-8529(05)70078-5","article-title":"Insulin-lowering therapeutic modalities for poly-cystic ovary syndrome","volume":"28","author":"Ehrmann","year":"1999","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib5","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1056\/NEJM199608293350902","article-title":"Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome","volume":"335","author":"Nestler","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib6","first-page":"165","article-title":"Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women","volume":"84","author":"Legro","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib7","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/0026-0495(94)90209-7","article-title":"Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy","volume":"43","author":"Velazquez","year":"1994","journal-title":"Metabolism"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib8","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1093\/oxfordjournals.humrep.a019118","article-title":"Acarbose reduces elevated testosterone serum concentrations in hyperinsuliaemic premenopausal women: a pilot study","volume":"11","author":"Geisthovel","year":"1996","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib9","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1093\/humrep\/16.10.2066","article-title":"Clinical, endocrine and metabolic effect of acarbose, an alpha-glucosidase inhibitor, in PCOS patients with increased insulin response and normal glucose tolerance","volume":"16","author":"Ciotta","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1093\/humrep\/deh580","article-title":"Comparison of the effects of acarbose and metformin use on ovulation rates in clomiphene citrate-resistant polycystic ovary syndrome","volume":"20","author":"Sonmez","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib11","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2165\/00044011-200222030-00001","article-title":"Acarbose: an update therapeutic use in diabetes treatment","volume":"22","author":"Laube","year":"2000","journal-title":"Clin Drug Invest"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib12","doi-asserted-by":"crossref","first-page":"94","DOI":"10.2165\/00003088-199630020-00002","article-title":"Pharmacokinetic-pharmacodynamic relationships of acarbose","volume":"30","author":"Salvatore","year":"1996","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib13","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1093\/humrep\/dei104","article-title":"Acarbose in obese patients with polycystic ovarian syndrome: a double-blind, randomized, placebo-controlled study","volume":"20","author":"Penna","year":"2005","journal-title":"Hum Reprod"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib14","first-page":"952","article-title":"The insulin resistance in women with hyperandrogenism is partially reversed by antiandrogen treatment: evidence that androgens impair insulin action in women","volume":"81","author":"Moghetti","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib15","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S0015-0282(16)58568-9","article-title":"Adrenal steroidogenesis is related to insulin in hyperandrogenic women","volume":"66","author":"Martikainen","year":"1996","journal-title":"Fertil Steril"},{"key":"10.1016\/j.fertnstert.2007.07.1326_bib16","doi-asserted-by":"crossref","first-page":"1951","DOI":"10.1093\/oxfordjournals.humrep.a136215","article-title":"Insulin resistant and nonresistant polycystic ovary syndrome represent two separate clinical and endocrinologic subgroups","volume":"10","author":"Meirow","year":"1995","journal-title":"Hum Reprod"}],"container-title":["Fertility and Sterility"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207029639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0015028207029639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T07:27:57Z","timestamp":1758007677000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0015028207029639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":16,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S0015028207029639"],"URL":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.07.1326","relation":{},"ISSN":["0015-0282"],"issn-type":[{"type":"print","value":"0015-0282"}],"subject":[],"published":{"date-parts":[[2008,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical, endocrine, and metabolic effects of acarbose, a \u03b1-glucosidase inhibitor, in overweight and nonoverweight patients with polycystic ovarian syndrome","name":"articletitle","label":"Article Title"},{"value":"Fertility and Sterility","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fertnstert.2007.07.1326","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 American Society for Reproductive Medicine. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}